Monday, May 29, 2017 9:58:34 AM
With all the management turnover in it's history, the revised PH3 requiring MORE patients and longer completion prospects look piss poor for achieving when there are better options for one's money from a partnering perspective.
When posters offer NOTHING of substance or content in their reply they're just in DELUSION & DENIAL.
DIFFERENT STROKES FOR DIFFERENT FOLKS.
DIFFERENT STROKES FOR DIFFERENT FOLKS
Recent IMUC News
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 08/02/2023 07:11:57 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM